Link Pharma Chem Ltd
Incorporated in 1986, Link Pharma Chem
Ltd is in the business of manufacturing
and job work of organic intermediate[1]
- Market Cap ₹ 10.7 Cr.
- Current Price ₹ 24.0
- High / Low ₹ 42.8 / 21.0
- Stock P/E 76.1
- Book Value ₹ 29.4
- Dividend Yield 0.00 %
- ROCE -3.00 %
- ROE -7.81 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.82 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -0.03% over past five years.
- Company has a low return on equity of -4.49% over last 3 years.
- Debtor days have increased from 56.4 to 72.0 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.59 | 17.58 | 12.35 | 16.10 | 23.53 | 24.50 | 25.47 | 34.81 | 53.56 | 38.76 | 29.90 | 25.43 | 27.28 | |
| 21.25 | 18.36 | 12.16 | 13.56 | 20.75 | 22.48 | 22.05 | 31.67 | 50.02 | 36.04 | 30.55 | 25.30 | 25.84 | |
| Operating Profit | 2.34 | -0.78 | 0.19 | 2.54 | 2.78 | 2.02 | 3.42 | 3.14 | 3.54 | 2.72 | -0.65 | 0.13 | 1.44 |
| OPM % | 9.92% | -4.44% | 1.54% | 15.78% | 11.81% | 8.24% | 13.43% | 9.02% | 6.61% | 7.02% | -2.17% | 0.51% | 5.28% |
| 0.26 | 0.21 | 2.39 | -0.43 | 0.07 | 0.19 | -0.69 | -0.15 | 0.46 | -0.15 | 0.64 | 0.19 | 0.18 | |
| Interest | 1.14 | 1.44 | 0.91 | 0.80 | 0.62 | 0.39 | 0.36 | 0.44 | 0.45 | 0.76 | 0.87 | 0.78 | 0.51 |
| Depreciation | 0.79 | 1.13 | 0.93 | 0.83 | 0.86 | 0.89 | 0.93 | 0.87 | 0.93 | 0.92 | 1.03 | 0.94 | 0.98 |
| Profit before tax | 0.67 | -3.14 | 0.74 | 0.48 | 1.37 | 0.93 | 1.44 | 1.68 | 2.62 | 0.89 | -1.91 | -1.40 | 0.13 |
| Tax % | 23.88% | -29.94% | 20.27% | 54.17% | 17.52% | 29.03% | 34.03% | 35.12% | 28.24% | 26.97% | -28.80% | -26.43% | |
| 0.52 | -2.20 | 0.59 | 0.23 | 1.13 | 0.66 | 0.95 | 1.08 | 1.88 | 0.65 | -1.36 | -1.03 | 0.14 | |
| EPS in Rs | 1.17 | -4.95 | 1.33 | 0.52 | 2.54 | 1.49 | 2.14 | 2.43 | 4.23 | 1.46 | -3.06 | -2.32 | 0.32 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 0% |
| 3 Years: | -22% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 133% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 0% |
| 3 Years: | -14% |
| 1 Year: | -31% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 1% |
| 3 Years: | -4% |
| Last Year: | -8% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 | 4.44 |
| Reserves | 6.23 | 3.93 | 4.52 | 4.16 | 5.35 | 5.94 | 6.99 | 8.12 | 10.03 | 10.60 | 9.27 | 8.22 | 8.63 |
| 9.08 | 10.80 | 5.41 | 4.73 | 2.71 | 2.64 | 3.56 | 3.66 | 6.39 | 8.76 | 9.22 | 5.78 | 8.10 | |
| 6.60 | 7.35 | 3.46 | 3.81 | 4.69 | 4.99 | 3.98 | 9.82 | 8.10 | 8.66 | 3.02 | 4.86 | 4.49 | |
| Total Liabilities | 26.35 | 26.52 | 17.83 | 17.14 | 17.19 | 18.01 | 18.97 | 26.04 | 28.96 | 32.46 | 25.95 | 23.30 | 25.66 |
| 14.59 | 17.51 | 10.13 | 9.57 | 9.76 | 9.14 | 8.81 | 8.71 | 8.79 | 9.00 | 9.94 | 9.28 | 9.94 | |
| CWIP | 1.92 | 0.00 | 0.00 | 0.00 | 0.01 | 0.43 | 0.00 | 0.00 | 0.21 | 0.00 | 0.00 | 0.00 | 0.09 |
| Investments | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 4.52 | 3.64 | 2.93 | 2.06 | 2.53 |
| 9.82 | 8.99 | 7.68 | 7.54 | 7.39 | 8.41 | 10.13 | 17.30 | 15.44 | 19.82 | 13.08 | 11.96 | 13.10 | |
| Total Assets | 26.35 | 26.52 | 17.83 | 17.14 | 17.19 | 18.01 | 18.97 | 26.04 | 28.96 | 32.46 | 25.95 | 23.30 | 25.66 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.87 | 5.13 | -3.91 | 2.23 | 3.79 | 1.36 | 2.95 | 4.84 | -1.26 | -1.71 | -0.03 | 2.69 | |
| -1.14 | -3.27 | 8.72 | -0.73 | -1.15 | -0.96 | -1.66 | -2.16 | -4.97 | -0.08 | 0.41 | 1.53 | |
| 0.30 | -0.87 | -5.75 | -1.48 | -2.63 | -0.46 | 0.55 | -0.33 | 2.27 | 1.61 | -0.41 | -4.21 | |
| Net Cash Flow | 0.03 | 0.99 | -0.94 | 0.02 | 0.00 | -0.05 | 1.85 | 2.35 | -3.95 | -0.17 | -0.03 | 0.00 |
| Free Cash Flow | -0.29 | 1.84 | 4.80 | 1.37 | 2.63 | 0.49 | 1.27 | 3.13 | -2.01 | -2.60 | -0.86 | 2.43 |
| CFO/OP | 37% | -658% | -2,005% | 92% | 147% | 77% | 83% | 169% | -17% | -48% | -52% | 2,046% |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 51.06 | 63.74 | 68.86 | 49.42 | 49.33 | 45.29 | 71.51 | 58.19 | 36.60 | 34.18 | 62.87 | 72.05 |
| Inventory Days | 143.28 | 125.34 | 277.34 | 285.97 | 96.96 | 92.54 | 60.04 | 51.35 | 47.68 | 209.23 | 135.89 | 166.94 |
| Days Payable | 110.60 | 94.59 | 81.61 | 202.93 | 124.25 | 108.98 | 110.86 | 140.70 | 45.37 | 112.90 | 38.51 | 101.21 |
| Cash Conversion Cycle | 83.74 | 94.49 | 264.59 | 132.47 | 22.05 | 28.85 | 20.68 | -31.16 | 38.90 | 130.51 | 160.24 | 137.78 |
| Working Capital Days | -9.90 | -46.92 | -6.80 | 0.23 | 31.64 | 31.43 | 51.45 | 10.49 | 14.17 | 26.74 | 5.13 | 15.07 |
| ROCE % | 9.32% | -8.74% | -3.64% | 13.00% | 15.41% | 10.34% | 18.71% | 14.61% | 13.16% | 6.72% | -4.79% | -3.00% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees Count |
|
|||||||||||
| Revenue Share - Job Work / Conversion Charges % |
||||||||||||
| Production Volume - Organic Intermediates MT |
||||||||||||
| Sales Volume - Organic Intermediates MT |
||||||||||||
| Installed Capacity - Organic Intermediates MT |
||||||||||||
Documents
Announcements
-
Closure of Trading Window
26 Mar - Trading window closed from 01 April 2026 until 48 hours after audited FY2026 results; board date to be intimated.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 Feb - Newspaper advertisement of unaudited financial results for the quarter and Nine months ended December 31, 2025
- We Herewith Submit Unaudited Financial Result For The Quarter And Nine Months Ended On 31St December, 2025 14 Feb
-
Board Meeting Outcome for We Herewith Submit Unaudited Financial Result For The Quarter And Nine Months Ended On 31St December, 2025
14 Feb - Approved unaudited Q3 and 9M results to Dec 31, 2025; 9M revenue Rs2,089.87 lakh; 9M PAT Rs28.55 lakh.
-
Board Meeting Intimation for To Consider And Approve Unaudited Financial Results For The Quarter And Nine Months Period Ended On 31St December, 2025
7 Feb - Board meeting on 14 Feb 2026 to approve Q3/9M unaudited results for period ended 31 Dec 2025; trading window closed.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
LPCL is engaged in the manufacturing and selling of organic /drug intermediates for Pharma, Agriculture, Cosmetics, Speciality Chemicals, and Veterinary industries.